Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze DNTH stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DNTH investment potential.

What is DNTH stock price today?

Get real-time DNTH stock price, historical data, and price charts on Financhill. Track DNTH performance with our advanced analysis tools.

Is DNTH a good investment?

Evaluate DNTH investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy DNTH stock?

To buy DNTH stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DNTH?

View detailed market capitalization data and company valuation metrics for DNTH on our comprehensive analysis page.

What is the P/E ratio of DNTH?

Use our fundamental analysis tools to view DNTH P/E ratio and compare valuation metrics with industry peers.

What are DNTH earnings?

View DNTH earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Dianthus Therapeutics, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

DNTH
Dianthus Therapeutics, Inc.

Last Price:

$44.26

Seasonality Move:

24.02%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

Dianthus Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Dianthus Therapeutics, Inc. has on average historically risen by 7.1% based on the past 7 years of stock performance.
Dianthus Therapeutics, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Is Dianthus Therapeutics, Inc. Stock Undervalued?

The current Dianthus Therapeutics, Inc. [DNTH] share price is $44.26. The Score for DNTH is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
DNTH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Dianthus Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Dianthus Therapeutics, Inc. has on average historically risen by 7.1% based on the past 7 years of stock performance.

Dianthus Therapeutics, Inc. Stock Rating

Buy

Dianthus Therapeutics, Inc. (DNTH) is a Buy

Is Dianthus Therapeutics, Inc. overpriced?

Dianthus Therapeutics, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Dianthus Therapeutics, Inc. Stock Price History

Is DNTH stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNTH is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

dianthustx.com

52-Week Data

52-Week High:

45.46

52-Week Low:

13.37

Prediction Charts

Market Cap:

1.9B

Price in USD:

44.26

Volume:

431K

Beta:

1.99

Technical Analysis

SMA50:

37.56

SMA100:

31.86

SMA200:

25.66

52-Wk Change:

87.07%

Stock Predictions

Is Dianthus Therapeutics, Inc. stock public?

Yes, Dianthus Therapeutics, Inc. is a publicly traded company.
What is the Dianthus Therapeutics, Inc. stock quote today?

The Dianthus Therapeutics, Inc. stock price is 44.26 USD today.
How to buy Dianthus Therapeutics, Inc. stock online?

You can buy Dianthus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	40.85	41.35	43.67	40.22
Nov-18	41.04	40.82	41.43	39.73
Nov-19	40.67	40.79	41.71	40.33
Nov-20	41.30	40.39	43.34	40.37
Nov-21	40.39	41.45	42.56	39.82
Nov-24	42.01	43.68	44.21	42.00
Nov-25	43.44	44.09	44.46	43.19
Nov-26	44.22	44.03	44.95	43.46
Nov-28	44.40	43.98	44.58	43.55
Dec-1	43.50	43.20	44.00	42.57
Dec-2	43.18	42.28	43.84	42.19
Dec-3	42.24	43.97	44.53	42.00
Dec-4	43.72	44.71	45.46	43.28
Dec-5	44.96	44.26	45.08	43.61

Dianthus Therapeutics, Inc. Earnings

Dianthus Therapeutics, Inc. Earnings Report: Per Share Dianthus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dianthus Therapeutics, Inc. Forecast Revenue Growth

Dianthus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Dianthus Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.47 per share, and a decrease next year of $0.13 per share.

* Dianthus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.